Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

First von Willebrand disease therapy heads new FDA approvals

Baxalta's Vonvendi set for an early 2016 launch in the US

- PMLiVE

Novel therapies for blood cancers showcased at ASH

Novartis' lead CAR-T therapy is one of those in the spotlight

- PMLiVE

UK Prix Galien opens for entries

Pharma R&D accolades will include a new real world evidence category

- PMLiVE

UK site a casualty as Pfizer reduces pain R&D

Will shut down Granta Park facility in Cambridge with loss of 120 jobs

Daiichi Sankyo logo

Daiichi Sankyo to shut down German antibody unit U3

Will transfer its operations to a research unit in Japan

Sanofi Espoir Foundation appoints new president

Xavier Darcos succeeds Jean-François Dehecq

Eli Lilly HQ

Lilly says insulin peglispro too risky to pursue

Discontinues development of medicine once tipped as a diabetes blockbuster

Face-to-face beats digital as prescribing influence

But report confirms doctors continue to embrace digital technology

- PMLiVE

Blue Latitude’s industry-first praised at PMEA

Support for Lilly and its Medical Information Cascade wins Innovation Award

- PMLiVE

Alexion’s rare bone disorder therapy rejected by NICE

Draft guidance rules Strensiq does not have a compelling enough evidence base

- PMLiVE

GSK’s severe asthma therapy Nucala gets EU nod

Becomes the first IL-5 inhibitor to be approved in the EU

- PMLiVE

Purdue Pharma appoints Dr Alan Dunton

He joins the pain specialist as senior VP of research and development

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links